AGXT and metabolic dysfunction-associated steatohepatitis: Unlike the mice with diet-induced MASH that demonstrated hepatic oxalate overproduction due to suppressed AGXT and enhanced LDHA activity, overexpression of AGXT or treatment with MDMG-935P in mice fed the standard chow diet had no significant effects on liver oxalate, indices of liver damage or lipid metabolism.